Research delves into how necroptosis affects immune cell infiltration and immunotherapy results in BLCA, revealing that necroptosis may boost CD8+ T cell infiltration and enhance the effectiveness of immune checkpoint inhibitors (Zhong et al., 2023). The gene discussed is CD8A; the disease is bladder transitional cell carcinoma.